Valeo Health

Dubai-based platform that delivers at-home blood tests, doctor visits, nursing, IV therapy and supplements in the UAE, Saudi Arabia, Qatar and Kuwait. It raised a USD 12 million Series B in March 2025.

Industry: Home healthcare and wellness | Location: Dubai, United Arab Emirates | Founded: 2021 | Total Funding: USD 15M

About Valeo Health

Valeo Health is a home healthcare and wellness platform headquartered in Dubai. Its website describes it as a technology-enabled service that brings personalised healthcare to customers. Services include at-home blood tests, IV therapy, physiotherapy, doctor on call and doctor at home visits, weight loss programmes, peptide therapy, newborn care and monthly personalised supplements. The company says it serves the United Arab Emirates, Saudi Arabia, Qatar and Kuwait.

Valeo launched in 2021. Wamda reported in June 2021 that it was founded by Sundeep Sahni, chief executive, and Nadine Karadag, chief operating officer, with an app for health tracking, at-home wellbeing tests and access to certified coaches. Wamda's March 2025 report names Ankur Majumder as a third co-founder, listed by Forbes Middle East as chief business officer. Forbes adds that Sahni previously co-founded the e-commerce company Lazada and that Karadag was a director in portfolio management at Growthgate Capital.

The website lists five locations in the UAE, including Dubai and Al Ain, as well as Riyadh and Doha. It states that Valeo holds ISO/IEC 27001:2022 certification, is HIPAA compliant, holds Dubai, Abu Dhabi and federal UAE health licences, and is listed with the Malaffi and NABIDH health information exchanges.

In July 2026 Khaleej Times reported a collaboration with Clemenceau Medical Center Dubai. Valeo customers can access services such as DEXA and MRI scans and specialist consultations through the hospital, and mothers who gave birth there can receive nursing, lactation guidance and postnatal physiotherapy at home.

Valeo raised a USD 3 million seed round in June 2021 from Nuwa Capital, Global Founders Capital, Global Ventures and FJ Labs, according to Wamda and GCC Business News. In March 2025 it announced a USD 12 million Series B led by Flintera, with Nuwa Capital, FJ Labs, Oryx, Mindshift Capital, Oraseya and Eirad, bringing total funding to USD 20 million, according to Wamda.

Forbes Middle East reported in September 2026 that Valeo had grown from two healthcare facilities to eight since January 2025, across Abu Dhabi, Qatar, Riyadh and Dubai, and that it passed one million diagnostic tests in 2026.

Leadership